Latest Articles

Publication Date
All News Scientific
Evaluating the Molecular Landscape in Endometrial Cancer to Optimize Treatment - Targeted Oncology

Evaluating the Molecular Landscape in Endometrial Cancer to Optimize Treatment Targeted Oncology

Published: Jan. 28, 2026, 10:02 p.m.
Read Full Article
Acrivon Therapeutics Announces Late-Breaking Oral Presentation at Upcoming European Society of Gynecological Oncology (ESGO) Annual International Congress - The Manila Times

Acrivon Therapeutics Announces Late-Breaking Oral Presentation at Upcoming European Society of Gynecological Oncology (ESGO) Annual International Congress The Manila Times

Published: Jan. 23, 2026, 1:20 p.m.
Read Full Article
Acrivon Therapeutics Announces Late-Breaking Oral Presentation at Upcoming European Society of Gynecological Oncology (ESGO) Annual International Congress - manilatimes.net

Acrivon Therapeutics Announces Late-Breaking Oral Presentation at Upcoming European Society of Gynecological Oncology (ESGO) Annual International Congress manilatimes.net

Published: Jan. 23, 2026, 1:20 p.m.
Read Full Article
Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer - Targeted Oncology

Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer Targeted Oncology

Published: Jan. 22, 2026, 4:02 p.m.
Read Full Article
Why Does Rina-S Target Folate Receptor Alpha in Endometrial Cancer? - Oncology Nursing News

Why Does Rina-S Target Folate Receptor Alpha in Endometrial Cancer? Oncology Nursing News

Published: Jan. 14, 2026, 7:32 p.m.
Read Full Article
No checkpoint glory for Acrivon | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

No checkpoint glory for Acrivon | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

Published: Jan. 12, 2026, 1:11 p.m.
Read Full Article
Novel Small Molecule Inhibitors Show Efficacy in Endometrial Cancer - Targeted Oncology

Novel Small Molecule Inhibitors Show Efficacy in Endometrial Cancer Targeted Oncology

Published: Jan. 11, 2026, 4:14 p.m.
Read Full Article
AnaptysBio seeks partial dismissal in GSK oncology unit dispute over drug royalty - ETPharma.com

AnaptysBio seeks partial dismissal in GSK oncology unit dispute over drug royalty ETPharma.com

Published: Jan. 10, 2026, 1:55 a.m.
Read Full Article
AnaptysBio seeks partial dismissal in GSK oncology unit dispute over drug royalty - ET Pharma

AnaptysBio seeks partial dismissal in GSK oncology unit dispute over drug royalty ET Pharma

Published: Jan. 10, 2026, 1:55 a.m.
Read Full Article
Using Lenvatinib/Pembrolizumab for Endometrial Cancer in Clinical Practice - Targeted Oncology

Using Lenvatinib/Pembrolizumab for Endometrial Cancer in Clinical Practice Targeted Oncology

Published: Jan. 5, 2026, 1:27 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!